Recent News

• 03.17.2026 - Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting
• 02.25.2026 - Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress

Recent Filings

• 03.13.2026 - 144 Report of proposed sale of securities
• 03.13.2026 - 144 Report of proposed sale of securities
• 03.13.2026 - 144 Report of proposed sale of securities
• 03.13.2026 - 144 Report of proposed sale of securities
• 03.13.2026 - 144 Report of proposed sale of securities
• 03.13.2026 - 144 Report of proposed sale of securities
• 03.13.2026 - 144 Report of proposed sale of securities
• 03.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2026 - 4 Statement of changes in beneficial ownership of securities